Published 4 days ago • loading... • Updated 3 days ago

InnovationRx: Recursion Launches Fund For Biotech Startups Hit By NIH Funding Cuts

Summary by Forbes

Plus: A shift in bird flu strategy, a new vaccine for meningococcal disease, a new AI genomics model from Nvidia and more.

3 Articles

All

Left

Center

Right

biopharmadive.com

Recursion CEO launches pre-seed fund in response to NIH cuts

Chris Gibson, Recursion’s head, cited the role small business grants played in helping his company grow its business.

4 days ago

Read Full Article

Forbes

InnovationRx: Recursion Launches Fund For Biotech Startups Hit By NIH Funding Cuts

Plus: A shift in bird flu strategy, a new vaccine for meningococcal disease, a new AI genomics model from Nvidia and more.

4 days ago·United States

Read Full Article

MedCity News

Recursion Pharma Accelerator Steps In to Fill Some of the Funding Gap Amid NIH Tumult

Altitude Lab Fund will provide pre-seed funding for early-stage startups affected by changes to grant programs administered by the National Institutes of Health. Accepted applicants will be admitted to Altitude Lab, the Salt Lake City biotech accelerator formed by Recursion Pharmaceuticals. The post Recursion Pharma Accelerator Steps In to Fill Some of the Funding Gap Amid NIH Tumult appeared first on MedCity News.

3 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Coverage Details

Total News Sources3

Leaning Left0Leaning Right0Center2Last Updated3 days agoBias Distribution

100% Center

Bias Distribution

100% of the sources are Center

100% Center

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Forbes broke the news in United States 4 days ago on Wednesday, February 19, 2025.

Sources are mostly out of (0)

InnovationRx: Recursion Launches Fund For Biotech Startups Hit By NIH Funding Cuts

3 Articles

3 Articles

Recursion CEO launches pre-seed fund in response to NIH cuts

Recursion CEO launches pre-seed fund in response to NIH cuts

InnovationRx: Recursion Launches Fund For Biotech Startups Hit By NIH Funding Cuts

InnovationRx: Recursion Launches Fund For Biotech Startups Hit By NIH Funding Cuts

Recursion Pharma Accelerator Steps In to Fill Some of the Funding Gap Amid NIH Tumult

Recursion Pharma Accelerator Steps In to Fill Some of the Funding Gap Amid NIH Tumult

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics